India Bioanalytical Testing Service Market Overview
Market Size in 2024: USD 111.13 Million
Market Forecast in 2033: USD 232.35 Million
Market Growth Rate: 8.50% (2025-2033)
According to the latest report by IMARC Group, the India bioanalytical testing service market size was valued at USD 111.13 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 232.35 Million by 2033, exhibiting a CAGR of 8.50% from 2025-2033.
India Bioanalytical Testing Service Industry Trends and Drivers:
Driven by growing demand for bioanalytical testing within the biopharmaceutical development industry, the India market for bioanalytical testing services is seeing strong growth. Accurate and dependable testing techniques are becoming increasingly necessary to guarantee drug effectiveness, safety, and regulatory compliance as the pharmaceutical industry keeps developing. This process depends mostly on bioanalytical testing since it is required for the evaluation of biological samples and medication substances. Especially in the disciplines of biologics and biosimilars, the increase in biopharmaceutical research and clinical trials is fueling the demand for these services. As a result, the bioanalytical testing market is flourishing as stakeholders work intently on improving service offerings to satisfy the expanding demands of the sector.
Moreover helping to drive market expansion is the use of automated and digital bioanalytical testing techniques. In the bioanalytical sector, the growing focus on accuracy and speed in testing techniques is driving broad application of cutting-edge technologies including artificial intelligence, high-throughput screening, and automation. These technical developments are improving the scalability, speed, and precision of testing services, therefore making them more accessible and efficient for research institutions and pharmaceutical firms. As the industry moves toward more digitized workflows, more attention is paid on integrating new technologies to simplify the testing procedure, lower expenses, and enhance general results. Market growth is likely to be driven on by this digital revolution.
Apart from technical advancements, the increasing number of collaborations between pharmaceutical companies and bioanalytical service providers is another important market growth engine. These partnerships let service providers provide customized bioanalytical solutions targeted toward the specific demands of several drug development phases. Research project growth combined with growing demand for bioanalytical services in clinical and preclinical phases offers great market opportunities. Demand for these services is further increasing the current trend toward subcontracting bioanalytical testing to specialized service providers. India's bioanalytical testing service market is set for consistent expansion in the years ahead as these collaborations grow.
Download sample copy of the Report: https://www.imarcgroup.com/India-Bioanalytical-Testing-Service-Market/requestsample
India Bioanalytical Testing Service Industry Segmentation:
The report has segmented the market into the following categories:
Molecular Type Insights:
- Small Molecule
- Large Molecule
- LC-MS Studies
- Immunoassays
- Others
Test Type Insights:
- ADME
- In-Vivo
- In-Vitro
- PK
- PD
- Bioavailability
- Bioequivalence
- Others
Workflow Insights:
- Sample Preparation
- Protein Precipitation
- Liquid-Liquid Extraction
- Solid Phase Extraction
- Sample Analysis
- Hyphenated Technique
- Chromatographic Technique
- Electrophoresis
- Ligand Binding Assay
- Mass Spectrometry
- Nuclear Magnetic Resonance
- Others
Regional Insights:
- North India
- South India
- East India
- West India
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
India Bioanalytical Testing Service Market News:
- In December 2024, Indian drugmaker Anthem Biosciences filed for a $397 million IPO, highlighting its expertise in bioanalytical testing services, including early-stage drug discovery and efficacy testing. The Bengaluru-based company also develops active pharmaceutical ingredients (APIs), dietary supplements, and probiotics, reinforcing India's growing contract research and bioanalytical testing market.
- In January 2023, Eurofins Scientific announced the expansion of its presence in the Indian pharmaceutical market with a new state-of-the-art campus in Genome Valley, Hyderabad. The acquisition included a facility with capabilities in synthetic organic chemistry, analytical R&D, bioanalytical services, in-vivo pharmacology, safety toxicology, and formulation R&D.
Key highlights of the Report:
- Market Performance (2019-2024)
- Market Outlook (2025-2033)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=32528&flag=C
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
